HCC tissue; adjacent normal tissues; peritumor tissues; tumor tissue; liver tissue; lung tissue
Hep3B; SK-HEP-1; MHCC97L; MHCC97H; Huh7; LO2; HEK293; HEK-293T
cell line-derived xenograft
Wnt/beta-catenin (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); metastasis (promotes); EMT (promotes); ceRNA regulation (promotes)
RT-qPCR; RNase R Treatment; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Survival Analysis; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Transfection; CCK8; Colony Formation Assay; EdU Staining; Annexin V/PI Flow Cytometry; Wound Healing Assay; Transwell Assay; IF (Immunofluorescence); Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); H&E Staining
High hsa_circRNA_104348 level is associated with poor prognosis in HCC patients.
hsa_circRNA_104348 (has_circ_104348) is up-regulated in hepatocellular carcinoma tissues and cell lines and is associated with worse overall survival. Functionally, it promotes HCC cell proliferation, migration, invasion and EMT-like changes while inhibiting apoptosis, and its knockdown suppresses tumor growth and lung metastasis in xenograft models. Mechanistically, it mainly localizes to the cytoplasm and acts as a ceRNA sponging miR-187-3p to increase RTKN2 and activate Wnt/beta-catenin signaling.
0.8428
CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/beta-catenin pathway.
combined biological and clinical study